GuruFocus.com via Yahoo
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions
Royalty Pharma PLC (RPRX) reports robust 15% growth in portfolio and royalty receipts, raises full-year guidance, and continues strategic acquisitions.
1 hour ago